TrialClinical cancer research : an official journal of the American Association for Cancer Research2022

Circulating Cell-free DNA as a Prognostic Biomarker in Patients with Advanced ALK+ Non-small Cell Lung Cancer in the Global Phase III ALEX Trial.

Rafal Dziadziuszko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.